RG 7600 companion diagnostic - Genentech

Drug Profile

RG 7600 companion diagnostic - Genentech

Alternative Names: 89Zr-MMOT0530A; DMOT 4039A companion diagnostic - Genentech; MMOT 0530A Zr 89; Zirconium-89 MMOT 0530A

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Genentech
  • Developer Genentech; University Medical Center Groningen; VU University Medical Center
  • Class Immunoconjugates; Monoclonal antibodies; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Ionising radiation emitters; Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Ovarian cancer; Pancreatic cancer

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Ovarian-cancer(Diagnosis) in Netherlands (Parenteral)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Pancreatic-cancer(Diagnosis) in Netherlands (Parenteral)
  • 01 May 2014 The University Medical Center Gronigen completes a phase I study for Pancreatic and Ovarian cancer (diagnosis) in the Netherlands (NCT01832116)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top